Pip Care to Improve Surgical Patient Outcomes
Launched by UNIVERSITY OF PITTSBURGH · Oct 24, 2024
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Pip Care trial is studying a new platform designed to help patients prepare for and recover from abdominal surgery. This platform includes a live health coach who works with patients and their families to make the surgical process easier to understand and manage. The goal is to help patients stay informed about their care and complete simple tasks that improve their outcomes. The trial will first test how easy the platform is to use and then compare the results of patients using Pip Care with those receiving standard care.
To participate in the trial, you must be at least 18 years old and scheduled for certain types of elective abdominal surgeries within the next 2 to 8 weeks. You also need to have daily access to a smartphone or tablet. Unfortunately, those who cannot speak English, need help using a smartphone or tablet, or are currently pregnant cannot take part. If you join, you can expect to receive personalized support from a health coach, who will help you set goals and coordinate your care throughout the surgical journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patient ≥18 years old
- • 2. Planned elective, inpatient surgery between 2 to 8 weeks following enrollment in Pip within the following surgical specialties: complex abdominal surgery (general surgery, colorectal surgery, surgical oncology), gynecologic oncology, thoracic surgery, spine surgery, and orthopedic joint surgery
- • 3. Daily access to a smartphone or tablet.
- Exclusion Criteria:
- • 1. Unable to speak English
- • 2. Unable to use a smartphone or tablet independently or with daily assistance.
- • 3. Currently pregnant (assessed via standard-of-care pre-operative workup)
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
New Castle, Pennsylvania, United States
Patients applied
Trial Officials
Jennifer Holder-Murray, MD
Principal Investigator
University of Pittsburgh, UPMC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported